Microbiome: Accelerating Innovation and Development (MAID) Hub

Liverpool City Region Life Sciences Innovation Zone Project.

The Microbiome: Accelerating Innovation and Development (MAID) Hub will drive development and commercialisation of microbiome therapies, novel antimicrobials and diagnostics for infectious disease.

Microbiomes - communities of microorganisms - offer a new frontier in tackling infectious disease, cancer, inflammatory bowel disease and mental health. They are also an important source of novel antimicrobials, such as bacteriophage that can act as alternatives to antibiotics and help to tackle global antimicrobial resistance (AMR). 

MAID will harness the world-leading expertise of the University of Liverpool’s Microbiome Innovation Centre (MIC), and national technology innovation centre, CPI, to provide end-to-end support for businesses and organisations seeking to de-risk and to accelerate microbiome and phage therapeutics to market.  

Through scientific consultancy, access to cutting-edge technology, a strong partnership network and a rich range of guidance relating to funding, regulatory, IP, manufacturing and more, MAID will position Liverpool as the place where life science innovators thrive.

Aligned with the UK’s ambition to be a global science and technology superpower, MAID builds on Liverpool’s strengths, positioning the Region as a leader in microbiome innovation, delivering local and global economic and healthcare benefits. Its impact is already evident: a microbiome-focused company relocated to the Region, and the BBSRC-funded Microbiome-Net, led by MIC, is supporting national activities.

The Liverpool City Region Life Sciences Innovation Zone Programme forms part of the Government’s national Investment Zone Programme, positioning the city region as a powerhouse for health and life sciences innovation.

Read more about the project here - Liverpool City Region to become global powerhouse in fighting disease and driving wellbeing.